NDCs not required under HHS rule
Executive Summary
Neither national drug codes nor the Healthcare Common Procedure Coding System would be required as the standard for reporting drugs and biologics for non-retail pharmacy transactions under HHS proposed rule. NDCs will remain the standard for retail pharmacy. The Pharmaceutical Research & Manufacturers of America wants NDCs to be used as the basis for Medicare reimbursement (1"The Pink Sheet" April 22, p. 36)...
You may also be interested in...
HCPCS Code Six-Month Marketing Prerequisite Is Unnecessary, PhRMA Says
The Centers for Medicare & Medicaid Services should eliminate the six-month marketing prerequisite for applying to receive an HCPCS code for Medicare reimbursement, PhRMA said in comments to HHS' Committee on Regulatory Reform
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.